$6.87
3.24% yesterday
Nasdaq, Dec 23, 10:00 pm CET
ISIN
US81728J1097
Symbol
SRTS

Sensus Healthcare, Inc. Stock price

$6.87
-1.91 21.75% 1M
+1.91 38.51% 6M
+4.51 191.10% YTD
+4.33 170.47% 1Y
-1.47 17.63% 3Y
+3.25 89.52% 5Y
+1.02 17.43% 10Y
Nasdaq, Closing price Mon, Dec 23 2024
-0.23 3.24%
ISIN
US81728J1097
Symbol
SRTS
Sector

Key metrics

Market capitalization $112.60m
Enterprise Value $90.69m
P/E (TTM) P/E ratio 12.03
EV/FCF (TTM) EV/FCF 43.39
EV/Sales (TTM) EV/Sales 2.20
P/S ratio (TTM) P/S ratio 2.73
P/B ratio (TTM) P/B ratio 2.08
Revenue growth (TTM) Revenue growth 65.60%
Revenue (TTM) Revenue $41.31m
EBIT (operating result TTM) EBIT $11.94m
Free Cash Flow (TTM) Free Cash Flow $2.09m
Cash position $22.56m
EPS (TTM) EPS $0.57
P/E forward 15.27
P/S forward 2.85
EV/Sales forward 2.30
Short interest 3.61%
Show more

Is Sensus Healthcare, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,892 stocks worldwide.

Sensus Healthcare, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Sensus Healthcare, Inc. forecast:

4x Buy
100%

Analyst Opinions

4 Analysts have issued a Sensus Healthcare, Inc. forecast:

Buy
100%

Financial data from Sensus Healthcare, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
41 41
66% 66%
100%
- Direct Costs 16 16
56% 56%
39%
25 25
72% 72%
61%
- Selling and Administrative Expenses 9.48 9.48
20% 20%
23%
- Research and Development Expense 3.33 3.33
20% 20%
8%
12 12
952% 952%
30%
- Depreciation and Amortization 0.41 0.41
21% 21%
1%
EBIT (Operating Income) EBIT 12 12
768% 768%
29%
Net Profit 9.31 9.31
1,146% 1,146%
23%

In millions USD.

Don't miss a Thing! We will send you all news about Sensus Healthcare, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sensus Healthcare, Inc. Stock News

Neutral
GlobeNewsWire
20 days ago
Full-service medical oncology practice to pioneer the use of SRT to treat companion animals for both home and veterinary clinic visits
Neutral
GlobeNewsWire
about one month ago
This revised news release replaces the one issued on November 14, 2024, contains several non-financial changes throughout and removes the name of and references to a new customer, at the customer's request. The agreement with the new customer remains in effect.
Positive
Seeking Alpha
about one month ago
Sensus Healthcare's Q3 results exceeded expectations with 127% YoY revenue growth and EPS of $0.07, showcasing strong demand recovery and effective management strategies. The Fair Deal Agreement and new FDA contracts, including a major deal with Platinum Dermatology, promise recurring revenue and reduced client concentration risk. Despite impressive financial performance, the stock saw minimal ...
More Sensus Healthcare, Inc. News

Company Profile

Sensus Healthcare, Inc. operates as a medical device company, which provides treatments for both oncological and non-oncological skin conditions. The firm's portfolio of treatment devices includes the SRT-100, SRT-100+ and SRT-100 Vision. Its main product, superficial radiation therapy (SRT), a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating basal cell and squamous cell skin cancers and other skin conditions such as keloids. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.

Head office United States
CEO Joseph Sardano
Employees 35
Founded 2010
Website www.sensushealthcare.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today